Get started
Author

Huakun Huang

Observed name: Hua-Kun Huang
OpenAlex ID: A5081601384
Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study
2022 · Shao-Hua Li, Jie Mei, et al. · Journal of Clinical Oncology · 188
PDF
Neoadjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria: An interim analysis of a multi-center, phase 3, randomized, controlled clinical trial.
2021 · Shaohua Li, Chong Zhong, et al. · Journal of Clinical Oncology · 25
Extensive serum biomarker analysis in patients with nasopharyngeal carcinoma
2018 · Daoyuan Gong, Ziping Li, et al. · Cytokine · 12
Case report: Primary hepatocellular carcinoma with portal vein tumor thrombus characterized by active tumor immune microenvironment achieving a complete response following treatment of combined immunotherapy
2022 · Kaihang Zhong, Yuyan Xu, et al. · Frontiers in Immunology · 10
PDF
Postoperative adjuvant hepatic arterial infusion chemotherapy (HAIC) with FOLFOX to improve outcomes of patients with hepatocellular carcinoma with microvascular invasion: A prospective multicenter, phase 3, randomized, controlled clinical trial.
2022 · Shaohua Li, Jie Mei, et al. · Journal of Clinical Oncology · 4
Co-amplification of Genes in Chromosome 8q24: a Robust Prognostic Marker in Hepatocellular Carcinoma
2021 · Yuan Cheng, Yongjian Zheng, et al. · Research Square
PDF
Co-amplification of Genes in Chromosome 8q24: a Robust Prognostic Marker in Hepatocellular Carcinoma
2021 · Yuan Cheng, Yongjian Zheng, et al. · Research Square
Works count: 7
Citation count: 239
H-index: 4
I10-index: 4
Year
Topic
Type